Sensorion reports full year 2016 results in line with status of clinical development

Read

Sensorion receives European authorization to initiate Phase II clinical trial of SENS-111 to treat acute vertigo

Read

2017 Financial Calendar

Read

Sensorion Inner Ear Disease Product Candidates and Technology Subject of Multiple Presentations at ARO MidWinter Meeting 2017

Read

Sensorion to Receive €950,000 from Bpifrance and the Occitania Region

Read

Pipeline

20190603 pipeline

Enregistrer

Patient center

Corporate presentation

Next events